These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11673575)

  • 1. Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Adelman JU; Lipton RB; Ferrari MD; Diener HC; McCarroll KA; Vandormael K; Lines CR
    Neurology; 2001 Oct; 57(8):1377-83. PubMed ID: 11673575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
    Bussone G; D'Amico D; McCarroll KA; Gerth W; Lines CR
    Eur Neurol; 2002; 48(3):172-7. PubMed ID: 12373035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
    Ashcroft DM; Millson D
    Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J; Fité B; López-Gil A
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rizatriptan: an update of its use in the management of migraine.
    Wellington K; Plosker GL
    Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on rizatriptan in migraine.
    Wellington K; Jarvis B
    CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scientific basis of medication choice in symptomatic migraine treatment.
    Goadsby PJ
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S20-6. PubMed ID: 10563229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
    Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S; Frishberg B; Hu XH; Markson L; Berger M
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
    Goldstein J; Ryan R; Jiang K; Getson A; Norman B; Block GA; Lines C
    Headache; 1998; 38(10):737-47. PubMed ID: 11284462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
    Tfelt-Hansen P; Teall J; Rodriguez F; Giacovazzo M; Paz J; Malbecq W; Block GA; Reines SA; Visser WH
    Headache; 1998; 38(10):748-55. PubMed ID: 11284463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
    Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
    Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
    Headache; 2004; 44(7):661-8. PubMed ID: 15209687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
    Gallagher RM; Dennish G; Spierings EL; Chitra R
    Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.